BGIM
IPXL

Brandywine Global Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Brandywine Global Investment Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-105,336
Closed -$1.7M – 961
2017
Q2 		$1.7M Sell
105,336
-7,784
-7% -$115K 0.01% 579
2017
Q1 		$1.43M Buy
113,120
+109,120
+2,728% +$1.32M 0.01% 579
2016
Q4 		$53K Buy
+4,000
New +$68.4K ﹤0.01% 821

Other funds holding IPXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Brandywine Global Investment Management's IPXL Position: Q3 2017 in Review

Brandywine Global Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 105,336 shares — an estimated $1.7M sold.

Brandywine Global Investment Management first reported a position in IPXL in Q4 2016 and held it in 3 quarters. The position peaked at $1.7M in Q2 2017. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

  • Brandywine Global Investment Management reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
  • Brandywine Global Investment Management sold 105,336 Impax Laboratories, Inc. shares in Q3 2017, an estimated $1.7M.
  • Brandywine Global Investment Management first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 3 quarters.
  • Brandywine Global Investment Management's Impax Laboratories, Inc. position peaked at $1.7M in Q2 2017.
  • 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Brandywine Global Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.